ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 132 filers reported holding ENANTA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.88 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $237,000 | -63.3% | 4,810 | -68.7% | 0.00% | -66.7% |
| Q4 2020 | $646,000 | -18.3% | 15,355 | -11.1% | 0.00% | -25.0% |
| Q3 2020 | $791,000 | -8.9% | 17,280 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $868,000 | -3.0% | 17,280 | -0.7% | 0.00% | -33.3% |
| Q1 2020 | $895,000 | -59.2% | 17,405 | -51.0% | 0.01% | -45.5% |
| Q4 2019 | $2,195,000 | -28.0% | 35,530 | -30.0% | 0.01% | -35.3% |
| Q3 2019 | $3,049,000 | -47.7% | 50,742 | -26.6% | 0.02% | -45.2% |
| Q2 2019 | $5,831,000 | +1038.9% | 69,102 | +1189.2% | 0.03% | +933.3% |
| Q1 2019 | $512,000 | +68.4% | 5,360 | +24.9% | 0.00% | +50.0% |
| Q4 2018 | $304,000 | -2.3% | 4,290 | +17.9% | 0.00% | 0.0% |
| Q3 2018 | $311,000 | – | 3,640 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 862,848 | $42,556,000 | 14.73% |
| Fairmount Funds Management LLC | 171,147 | $8,441,000 | 3.56% |
| ARMISTICE CAPITAL, LLC | 1,648,000 | $81,279,000 | 1.87% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,995,000 | $98,393,000 | 0.49% |
| Jackson Creek Investment Advisors LLC | 21,409 | $1,056,000 | 0.37% |
| Hennion & Walsh Asset Management, Inc. | 113,940 | $5,620,000 | 0.34% |
| Virtus ETF Advisers LLC | 14,721 | $726,000 | 0.31% |
| Granahan Investment Management | 193,416 | $9,539,000 | 0.20% |
| Yorktown Management & Research Co Inc | 4,500 | $222,000 | 0.18% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 242,257 | $11,948,000 | 0.09% |